Fluoroscopy is often used to improve LP success rates in challenging cases, but reliance on fluoroscopic guidance poses cumulative radiation risks, which is particularly concerning for pediatric ...
Independent research from Johns Hopkins validates Lantern's data used to secure the FDA Rare Pediatric Disease Designation for LP-184 in ATRT and supports planned pediatric clinical trial The data ...
CHARLOTTESVILLE, Va., Sept. 4, 2025 /PRNewswire/ -- RIVANNA®, developers of world-first imaging-based medical technologies, has been awarded a $2.21 million Small Business Innovation Research (SBIR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results